However, for many, this journey has been slow and with many bumps along the way. While it’s always difficult to bring about cultural, strategic, and operational transformation in large organizations, the structural complexity of the health care environments in which many Pharma and Biotech firms are operating makes profound organizational change even more difficult.
As managers work to make their organizations more patient-centric, even basic questions such as “what do we mean when we state that we are patient-centric?”, “what processes do we need to have in place?”, “are we making progress?” or, simply, “how do we get started in transforming our company?” frequently arise.
This whitepaper explores the advancement of patient centricity across the industry and offers tips on how pharma and biotech firms can successfully navigate the patient centricity journey.
